The European & Developing Countries Clinical Trials Partnership (EDCTP) is a public-public partnership between countries in Europe and sub-Saharan Africa. It is supported by Horizon 2020, the European Union’s Framework Programme for Research and Innovation
EDCTP is a research initiative where currently 14 European and 16 African member states work together to fight poverty-related and neglected diseases. EDCTP supports clinical research with a focus on phase II and III clinical trials. Funding aim at accelerating the development of new or improved drugs, vaccines, microbicides and diagnostics for HIV/AIDS, tuberculosis and malaria as well as other poverty-related infectious diseases in sub-Saharan Africa. A further priority is building research capacity in Africa, which the EDCTP supports through an extensive stipend programme: Coordination & Support Actions (CSAs) aim at strengthening research capacities in sub-Saharan Africa and promote collaboration between European and African researchers. Training & Mobility Actions (TMAs) foster career development for individual junior and senior fellows and stimulate the mobility of researchers and research staff.
Multinational Funding and Calls
The EDCPT programme was founded in 2003 and is currently in the second funding period. EDCTP1 ran from 2003 to 2014, awarded a total funding of €208 million and was supported with about €20 million by the German government. In 2014 the second EDCTP programme started. The European Union will provide a contribution of up to €683 million for the 10-year programme (2014-2024).The German contribution to EDCTP2 is expected to amount to €110 million. Discussions on a follow-up programme “EDCTP3” are ongoing.
Several calls for proposals are announced each year, supported through three distinct types of Horizon 2020 instruments.